Clinical Trials on Salivary Immunity in Hong Kong

Total 11 results

Chinese University of Hong Kong

Recruiting

Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation

Parotid Neoplasms

Hong Kong
The University of Hong Kong

Completed

Promoting Smoking Cessation in the Community Via Quit to Win Contest 2012

Comparative Effectiveness Research | Community-Based Participatory Research

China
Chinese University of Hong Kong

Recruiting

Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit

Community-acquired Pneumonia

Hong Kong
Nutricia Research

Completed

A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy (TEMPO)

Immunity

Hong Kong, Taiwan, Singapore, Netherlands, Israel, Spain, United Kingdom, Slovakia, Belgium, Germany, Czechia, Hungary, Italy
National Cancer Institute (NCI)

Completed

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (MAESTRO HN)

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Salivary Gland Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Nasopharyngeal Keratinizing Squamous... and other conditions

United States, China
Mahidol University
Chulalongkorn University; Ministry of Health, Thailand; Yuvabadhana foundation; Zero COVID Thailand

Completed

The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community

Coronavirus Infections | Covid19 | SARS-CoV-2 | Community Transmissions

Thailand
Pfizer

Completed

Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia

Community-Acquired Pneumonia (CAP)

United States, Canada, Germany, Greece, Spain
VA Office of Research and Development

Completed

Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) (ESCAPe)

Community Acquired Respiratory Disease Syndrome

United States, Puerto Rico
Hoffmann-La Roche

Active, not recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)

Melanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditions

United States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland
Forest Laboratories
AstraZeneca

Completed

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Infections | Community Acquired Pneumonia

Spain, United States, Argentina, Bulgaria, Georgia, Greece, Hungary, Poland, Ukraine
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage I Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Dermatofibrosarcoma Protuberans | Adult Angiosarcoma | Adult Epithelioid Sarcoma | Adult Extraskeletal Osteosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma and other conditions

United States, Canada, Australia, New Zealand, Puerto Rico

Clinical Trials on Salivary Immunity in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations